A Deep Dive Into Food Allergy: Dr. Kari Nadeau and Rob Reid on the “After On” podcast
The prevalence of food allergies in the U.S. is greater than it’s ever been before, roughly doubling every ten years. Diagnoses of anaphylactic food reactions have risen by 377 percent since 2007, according to recent FARE-commissioned data.
The prevalence of food allergies in the U.S. is greater than it’s ever been before, roughly doubling every ten years. Diagnoses of anaphylactic food reactions have risen by 377 percent since 2007, according to recent FARE-commissioned data.
To address this concerning trend, Dr. Kari Nadeau, MD, PhD, the director of the Sean N. Parker Center for Allergy Research at Stanford University and FARE’s medical advisor for innovation, sat down for an interview with Rob Reid on the “After On” podcast to discuss this public health crisis and the groundbreaking research underway to develop new therapies and diagnostic tools.
In Dr. Nadeau’s conversation with Rob, you’ll learn about the Sean Parker Center at Stanford University, which conducts research on allergy and asthma and, through its fundraising efforts, enables food allergy research at more than 100 different sites around the globe. You’ll also get a brief but informative history of food allergies and how we’ve gotten to where we are today with food allergies and anaphylactic reactions at record highs.
Throughout the show, Dr. Nadeau breaks down complex physiological and medical topics pertaining to food allergies — from the role different antibodies play in food allergy reactions to the development of new treatments like oral immunotherapies — in a way that is easy to understand and will allow the average listener to walk away with a thorough understanding of this disease and how it affects the 32 million Americans with food allergies.
Take a listen to the interview and if you want to learn more about the prevalence of food allergy and what we can do to find a cure, check out FARE’s Contains: Courage™ campaign at www.foodallergy.org/containscourage. Together, we can drive research forward to develop new therapies, diagnostics and approaches to prevention.